Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Willingness to participate in prevention programs for cardiometabolic diseases

Authors: Jessica Petter, Margreet M Reitsma-van Rooijen, Joke C Korevaar, Markus MJ Nielen

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Cardiometabolic diseases are the leading cause of death worldwide and result in decreased quality of life for patients and increased healthcare costs. Population-based prevention programs may prevent the onset and development of cardiometabolic diseases. The effectiveness of these programs depends on participation rates. This study identified factors related to willingness to participate in health checks and lifestyle intervention programs to prevent cardiometabolic diseases.

Methods

A questionnaire was sent to 1,500 Dutch adults, participating in the Dutch Health Care Consumer Panel of NIVEL. The questionnaire was developed by NIVEL. Predictors of willingness to participate were identified with logistic regression analyses. Predictors investigated were socio-demographic variables, risk factors for cardiometabolic diseases and motivational aspects.

Results

The response rate was 63%. 56% of the participants in our study were willing to participate in a health check. Higher age was associated with increased willingness to participate, as was the desire to know the actual risk for cardiometabolic diseases (OR = 4.6). Becoming unnecessarily worried was identified as a barrier (OR = 0.3). 47% were willing to participate in a lifestyle intervention program. People aged 39–65 were most willing to participate. Attention for prevention relapse behavior (OR = 3.3), informing the general practitioner about results (OR = 2.6) and conducting the program in a group (OR = 2.0) were positively associated with willingness to participate in lifestyle interventions.

Conclusions

Willingness to participate in a health check depended on personal beliefs, whereas social aspects contributed most to willingness to participate in a lifestyle intervention program. This information can be used to optimize and tailor the promotion of prevention programs.
Literature
1.
World Health Organization. Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: WHO Press; 2011.
2.
3.
Tourlouki E, Matalas AL, Panagiotakos DB. Dietary habits and cardiovascular disease risk in middle-aged and elderly populations: a review of evidence. Clin Interv Aging. 2009;4:319.CrossRefPubMedPubMedCentral
4.
Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland coronary prevention study. Circulation. 2003;108:414–9.CrossRefPubMed
5.
Repas TB. Challenges and strategies in managing cardiometabolic risk. J Am Osteopath Assoc. 2007;107:S4–11.PubMed
6.
Rice BH, Cifelli CJ, Pikosky MA, Miller GD. Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research. Adv Nutr. 2011;2:396–407.CrossRefPubMedPubMedCentral
7.
Kraushaar LE, Kramer A. Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health. 2009;9:64.CrossRefPubMedPubMedCentral
8.
Laws RA, Fanaian M, Jayasinghe UW, McKenzie S, Passey M, Davies GP, et al. Factors influencing participation in a vascular disease prevention lifestyle program among participants in a cluster randomized trial. BMC Health Serv Res. 2013;13:201.CrossRefPubMedPubMedCentral
9.
Ma J, King A, Wilson S, Xiao L, Stafford R. Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial. BMC Fam Pract. 2009;10:71.CrossRefPubMedPubMedCentral
10.
Unal B, Critchley JA, Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, 1981–2000: comparing contributions from primary prevention and secondary prevention. BMJ. 2005;331:614.CrossRefPubMedPubMedCentral
11.
National Institute for Clinical Excellence. Prevention of Cardiovascular Disease at Population Level. Manchester: NICE; 2010.
12.
Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T. The global burden of cardiovascular disease. Eur J Cardiovasc Nur. 2011;10:S5–13.CrossRef
13.
Assendelft WJ, Nielen MM, Hettinga DM, van der Meer V, van Vliet M, Drenthen AJ, et al. Bridging the gap between public health and primary care in prevention of cardiometabolic diseases; background of and experiences with the prevention consultation in The Netherlands. Fam Pract. 2012;29:i126–31.CrossRefPubMedPubMedCentral
14.
van der Meer V, Nielen MM, Drenthen AJ, van Vliet M, Assendelft WJ, Schellevis FG. Cardiometabolic prevention consultation in the Netherlands: screening uptake and detection of cardiometabolic risk factors and diseases–a pilot study. BMC Fam Pract. 2013;14:29.CrossRefPubMedPubMedCentral
15.
Lakerveld J, IJzelenberg W, Van Tulder MW, Hellemans IM, Rauwerda JA, Van Rossum AC, et al. Motives for (not) participating in a lifestyle intervention trial. BMC Med Res Methodol. 2008;8:17.CrossRefPubMedPubMedCentral
16.
Elzen H, Slaets JP, Snijders TA, Steverink N. Do older patients who refuse to participate in a self-management intervention in the Netherlands differ from older patients who agree to participate. Aging Clin Exp Res. 2008;20:266–71.CrossRefPubMed
17.
Koopmans B, Nielen MM, Schellevis FG, Korevaar JC. Non-participation in population-based disease prevention programs in general practice. BMC Public Health. 2012;12:1–10.CrossRef
18.
Robroek SJ, Van Lenthe FJ, Van Empelen P, Burdorf A. Determinants of participation in worksite health promotion programmes: a systematic review. Int J Behav Nutr Phys Act. 2009;6:26–37.CrossRefPubMedPubMedCentral
19.
Lambert AM, Burden AC, Chambers J, Marshall T. Cardiovascular screening for men at high risk in heart of Birmingham teaching primary care trust: the deadly trio programme. J Public Health. 2012;34:73–82.CrossRef
20.
Wall M, Teeland L. Non-participants in a preventive health examination for cardiovascular disease: characteristics, reasons for non-participation, and willingness to participate in the future. Scand J Prim Health Care. 2004;22:248–51.CrossRefPubMed
21.
Nielsen KDB, Dyhr L, Lauritzen T, Malterud K. You can’t prevent everything anyway: a qualitative study of beliefs and attitudes about refusing health screening in general practice. Fam Pract. 2004;21:28–32.CrossRefPubMed
22.
Groeneveld IF, Proper KI, Van Der Beek AJ, Hildebrandt VH, Van Mechelen W. Factors associated with non-participation and drop-out in a lifestyle intervention for workers with an elevated risk of cardiovascular disease. Int J Behav Nutr Phys Act. 2009;6:80.CrossRefPubMedPubMedCentral
23.
Vermunt PWA, Milder IEJ, Wielaard F, Van Oers JAM, Westert GP. An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study. Fam Pract. 2010;27:312–9.CrossRefPubMed
24.
Toft UN, Kristoffersen LH, Aadahl M, von Huth Smith L, Pisinger C, Jørgensen T. Diet and exercise intervention in a general population: mediators of participation and adherence: the Inter99 study. Eur J Public Health. 2007;17:455–63.CrossRefPubMed
25.
van Gils PF, Lambooij MS, Flanderijn MH, van den Berg M, de Wit GA, Schuit AJ, et al. Willingness to participate in a lifestyle intervention program of patients with type 2 diabetes mellitus: a conjoint analysis. Patient Prefer Adherence. 2011;5:537–46.CrossRefPubMedPubMedCentral
26.
Van der Weijden T, Van Steenkiste B, Stoffers HEJH, Timmermans DRM, Grol RPTM. Primary prevention of cardiovascular diseases in general practice: mismatch between cardiovascular risk and patients’ risk perceptions. Med Decis Making. 2007;27:754–61.CrossRefPubMed
27.
Schmidt M, Absalah S, Nierkens V, Stronks K. Which factors engage women in deprived neighbourhoods to participate in exercise referral schemes? BMC Public Health. 2008;8:371.CrossRefPubMedPubMedCentral
28.
Murray J, Honey S, Hill K, Craigs C, House A. Individual influences on lifestyle change to reduce vascular risk: a qualitative literature review. Br J Gen Pract. 2012;62:e403–10.CrossRefPubMedPubMedCentral
29.
Brabers AEM, Reitsma-van Rooijen M, de Jong JD. Consumentenpanel Gezondheidszorg. Basisrapport met informatie over het panel (2012). Utrecht: NIVEL; 2012.
30.
Centraal Bureau voor de Statistiek. Bevolking; geslacht, leeftijd en burgerlijke staat, 1 januari. Den Haag/Heerlen. 2014 (www.​cbs.​nl).
Metadata
Title
Willingness to participate in prevention programs for cardiometabolic diseases
Authors
Jessica Petter
Margreet M Reitsma-van Rooijen
Joke C Korevaar
Markus MJ Nielen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1379-0

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Research article

The educational gradient of obesity increases among Swedish pregnant women: a register-based study

Research article

Assessing the risk factors of cholera epidemic in the Buea Health District of Cameroon

Research article

Screening for pulmonary tuberculosis in type 2 diabetes elderly: a cross-sectional study in a community hospital

Research article

Does the type of abortion provider influence contraceptive uptake after abortion? An analysis of longitudinal data from 64 health facilities in Ghana

Research article

Beyond resistance: social factors in the general public response to pandemic influenza

Erratum

Erratum to: A novel antigen capture ELISA for the specific detection of IgG antibodies to elephant endotheliotropic herpes virus